ATE162310T1 - Nachweis von heparinbindenden seminalproteinen - Google Patents

Nachweis von heparinbindenden seminalproteinen

Info

Publication number
ATE162310T1
ATE162310T1 AT90308341T AT90308341T ATE162310T1 AT E162310 T1 ATE162310 T1 AT E162310T1 AT 90308341 T AT90308341 T AT 90308341T AT 90308341 T AT90308341 T AT 90308341T AT E162310 T1 ATE162310 T1 AT E162310T1
Authority
AT
Austria
Prior art keywords
heparin
binding
detection
seminal
proteins
Prior art date
Application number
AT90308341T
Other languages
English (en)
Inventor
Roy L Ax
David J Miller
Martin A Winer
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Application granted granted Critical
Publication of ATE162310T1 publication Critical patent/ATE162310T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, e.g. Konjac gum, Locust bean gum, Guar gum
    • G01N2400/40Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/36Gynecology or obstetrics
    • G01N2800/367Infertility, e.g. sperm disorder, ovulatory dysfunction
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/906Fertility tests
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/85Reproductive organs or embryos
    • Y10S530/852Sperm

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT90308341T 1989-07-28 1990-07-30 Nachweis von heparinbindenden seminalproteinen ATE162310T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38695489A 1989-07-28 1989-07-28

Publications (1)

Publication Number Publication Date
ATE162310T1 true ATE162310T1 (de) 1998-01-15

Family

ID=23527796

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90308341T ATE162310T1 (de) 1989-07-28 1990-07-30 Nachweis von heparinbindenden seminalproteinen

Country Status (4)

Country Link
US (1) US5434139A (de)
EP (1) EP0410816B1 (de)
AT (1) ATE162310T1 (de)
DE (1) DE69031928T2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5346990A (en) * 1987-04-08 1994-09-13 Cytogam, Inc. Sex-associated membrane proteins and methods for increasing the probability that offspring will be of a desired sex
US5962241A (en) * 1989-07-28 1999-10-05 The University Of Arizona Monoclonal antibody detection of proteins on sperm related to fertility
CA2143053A1 (en) * 1994-03-14 1995-09-15 Jorge G. Tezon Induction of the acrosome reaction to evaluate the fertilization capability of mammalian sperm
US20050049401A1 (en) * 2003-08-29 2005-03-03 The Arizona Board Of Regents... Fertility prediction of mammalian males and polyclonal antibodies for the prediction thereof
DE102005028453A1 (de) * 2005-06-17 2006-12-28 Philipps-Universität Marburg Verfahren zur Bestimmung und Beeinflussung der Fertilität männlicher Säugetiere und des Menschen
US20070049739A1 (en) * 2005-08-30 2007-03-01 Biomet Manufacturing Corp. Method and system for extracting blood-derived growth factors
JP6182574B2 (ja) 2008-10-31 2017-08-16 ビオメリュー・インコーポレイテッド 分光法を使用した微生物の分離、キャラクタリゼーションおよび/または同定方法
RU2510844C2 (ru) * 2008-10-31 2014-04-10 Биомерьё, Инк. Контейнер для изоляции и идентификации микроорганизма

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4446122A (en) * 1979-12-28 1984-05-01 Research Corporation Purified human prostate antigen
IT1197670B (it) * 1983-06-29 1988-12-06 Serono Ist Farm Frazione antigenica seminale purificata,procedimento per la sua preparazione ed impiego della stessta per il dosaggio degli anticorpi spermioagglutinanti
US4767703A (en) * 1984-04-03 1988-08-30 Wisconsin Alumni Research Foundation Method for assessing the fertility of male mammals

Also Published As

Publication number Publication date
DE69031928T2 (de) 1998-05-20
US5434139A (en) 1995-07-18
EP0410816A2 (de) 1991-01-30
DE69031928D1 (de) 1998-02-19
EP0410816B1 (de) 1998-01-14
EP0410816A3 (en) 1992-10-07

Similar Documents

Publication Publication Date Title
DK339883A (da) Krystallinske silicoaluminophosphater, fremgangsmaade til fremstilling samt anvendelse heraf
DE3788397T3 (de) Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung.
AR240916A2 (es) "un procedimiento para la preparacion de nuevos derivados de n(fenil)amino)carbonil) bencensulfonamida".
ATE68826T1 (de) Verfahren zur herstellung von reifem, menschlichem serum-albumin.
PT81991B (pt) Processo para a preparacao de derivados peptidicos, analogos a pepestatina, inibidores darenina e das proteases acidas
ES2115756T3 (es) Derivados de acido sulfonico utilizados en el tratamiento de enfermedades virales.
ATE162310T1 (de) Nachweis von heparinbindenden seminalproteinen
DE3574479D1 (de) Citronensaeureester als treibmittel zur kunststoffverarbeitung.
ATE355375T1 (de) Bakterioferritin aus helicobacter pylori
DE68912462D1 (de) Xanthenfarbstoffe.
ATE5314T1 (de) Pharmakologisch aktive peptide und deren zusammensetzungen.
DK482185D0 (da) Peptider, deres fremstilling og anvendelse som laegemidler
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
FI945877A (fi) Menetelmä proteiini C:n tuottamiseksi
ATE130009T1 (de) Antitumor-aminosäuren und peptid-derivate von 1,4-bis((aminoalkyl und hydroxyaminoalkyl)amino>5,8- dihydroxyanthraquinonen.
DK0876610T3 (da) Fremgangsmåde og anvendelse af polypeptid i sædcelle-æg-binding til at foröge eller mindske fertilitet
BR8600260A (pt) Processo para a preparacao de triacetoxissilanas a partir de tris(amino)silanas
KR890008166A (ko) 융합 단백질의 선택적 분해 방법
PT89742A (pt) Processo de preparacao de 24r-cimnol e de suas composicoes farmaceuticas
FI911447A0 (fi) Kermesbaerets antivirusproteinmonoklonal antikropp-konjugationer.
EP0285361A3 (de) Reinigung von Apase-1 und Wiedererlangung des Nematodenresistenzgens
DK628188D0 (da) Protein og fremgangsmaade til fremstilling deraf
EP0194977A3 (en) Method of lighting generic interiors, in particular so-called open-space work interiors
ATE110853T1 (de) Immuntestverfahren für zelluläres eiweiss.
DK0674718T3 (da) Fremgangsmåde til identifikation af individer smittet med HIV og overvågning af deres terapi

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties